highly significantp < 0.0001
As expected, FSHD2 patients showed a highly significant (Mann–Whitney U test; p < 0.0001) D4Z4 hypomethylation (11 ± 7%; range 3–30%) compared to controls (51 ± 12%; range 19–76%).
As expected, FSHD2 patients showed a highly significant (Mann–Whitney U test; p < 0.0001) D4Z4 hypomethylation (11 ± 7%; range 3–30%) compared to controls (51 ± 12%; range 19–76%).